Viking Therapeutics
VKTX
24.77
-1.07
-4.14%
Viking Therapeutics
US · VKTX
#2352 by market cap
Listed 2015
24.77
-1.07
-4.14%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:56
Quant vs Street three independent views, side by side
StockVane factor grade
C
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 16 analysts
Buy
Avg price target 93.53 +277.6%
Price target rangecurrent 24.77
Low34.00
Avg93.53
High125.00
Buy 94%
Hold 6%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-30 | CCORF | -- | Buy | 118.00 |
| 2026-10-30 | Maxim Group | -- | Buy | 70.00 |
| 2026-10-29 | UBS | -- | Buy | 94.00 |
| 2026-10-29 | Piper Sandler | -- | Buy | 90.00 |
| 2026-10-29 | Maxim Group | -- | Buy | 70.00 |
| 2026-10-29 | BTIG | -- | Buy | 125.00 |
| 2026-10-29 | Morgan Stanley | -- | Buy | 95.00 |
| 2026-10-29 | Stifel | -- | Buy | 95.00 |
| 2026-10-29 | B. Riley Securities | -- | Buy | 85.00 |
| 2026-10-29 | H.C. Wainwright | -- | Buy | 102.00 |
| 2026-10-29 | Oppenheimer | -- | Buy | 120.00 |
| 2026-10-28 | Cantor Fitzgerald | -- | Buy | 100.00 |
| 2026-10-28 | Goldman Sachs | -- | Hold | 34.00 |
| 2026-10-20 | CCORF | -- | Buy | 106.00 |
| 2026-10-15 | UBS | -- | Buy | 94.00 |
| 2026-10-14 | CCORF | -- | Buy | 114.00 |
| 2026-10-14 | H.C. Wainwright | -- | Buy | 102.00 |
| 2026-10-07 | CCORF | -- | Buy | 114.00 |
| 2026-10-07 | Truist Financial | -- | Buy | 85.00 |
| 2026-10-06 | Maxim Group | -- | Buy | 70.00 |
| 2026-10-06 | Morgan Stanley | -- | Buy | 95.00 |
| 2026-10-06 | H.C. Wainwright | -- | Buy | 102.00 |
| 2026-09-23 | CCORF | -- | Buy | 114.00 |
| 2026-09-23 | Maxim Group | -- | Buy | 70.00 |
| 2026-09-23 | Truist Financial | -- | Buy | 87.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-10-28 | After close | ±6.78% | +5.91% (in line) |
| 2026/Q2 | 2026-07-29 | After close | ±9.38% | -0.96% (in line) |
| 2026/Q1 | 2026-04-29 | After close | ±7.30% | -0.48% (in line) |
| 2025/Q4 | 2026-02-11 | After close | ±10.92% | +6.80% (in line) |
| 2025/Q3 | 2025-10-22 | After close | ±7.93% | +7.96% (beat) |
| 2025/Q2 | 2025-07-23 | After close | ±11.88% | +0.30% (in line) |
| 2025/Q1 | 2025-04-23 | After close | ±10.16% | -0.50% (in line) |
| 2024/Q4 | 2025-02-05 | After close | ±11.71% | -6.09% (in line) |
| 2024/Q3 | 2024-10-23 | After close | ±9.93% | +21.25% (beat) |
| 2024/Q2 | 2024-07-24 | After close | ±15.95% | +28.31% (beat) |
| 2024/Q1 | 2024-04-24 | After close | ±9.78% | +5.82% (in line) |
| 2023/Q4 | 2024-02-07 | After close | ±20.17% | +18.01% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:56:05 · For reference only, not investment advice and not tailored to your situation.
Viking Therapeutics discussion 0 comments